Synlogic (NASDAQ:SYBX) Shares Cross Below Fifty Day Moving Average – Time to Sell?

Synlogic, Inc. (NASDAQ:SYBX) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.40 and traded as low as $1.38. Synlogic shares last traded at $1.39, with a volume of 2,106 shares changing hands.

Synlogic Price Performance

The company has a market cap of $16.20 million, a P/E ratio of -0.33 and a beta of 0.81. The company has a fifty day simple moving average of $1.40 and a 200-day simple moving average of $1.43.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.